How Much Is A Priority Review Voucher Worth? Perhaps $387 Mil.
Executive Summary
There's no real market for priority review vouchers; indeed, it seems like there is only one voucher in existence at the moment – Novartis' coupon from the Coartem approval.
You may also be interested in...
Paladin’s Impavido Could Set A Price Tag For Priority Review Vouchers
Approval of the leishmaniasis treatment by its December user fee date would give the Canadian sponsor a voucher for a priority review, which it is likely to sell to another company.
Ilaris Complete Response Letter Raises Questions About The Validity of Priority Review Vouchers
What’s a Priority Review Voucher worth? That’s a complicated question now that the first voucher used on an application, from drug maker Novartis AG for Ilaris (canakinumab), has received a complete response letter from US regulators.
Ilaris Complete Response Letter Raises Questions About The Validity of Priority Review Vouchers
What’s a Priority Review Voucher worth? That’s a complicated question now that the first voucher used on an application, from drug maker Novartis AG for Ilaris (canakinumab), has received a complete response letter from US regulators.